The total return over the past 12 months is +6.71% vs. +17.49% for the S&P 500. So far it's up -8.23% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +5.98% | +16.14% | +10.71% | +18.84% | +23.36% | N/A |
| Total Return CAGR | +6.71% | +17.04% | +11.63% | +19.72% | +25.30% | N/A |
| Revenue CAGR | +7.31% | +8.00% | +6.85% | +6.73% | +6.23% | +5.86% |
| Net Income CAGR | +14.55% | +5.83% | +6.61% | +11.12% | +13.71% | +8.74% |
| EPS CAGR | +24.47% | +13.76% | +20.90% | +18.28% | +16.68% | +11.51% |
| Free Cash Flow CAGR | (17.76%) | +6.73% | +56.45% | +7.67% | +8.21% | +12.62% |
| Operating Cash Flow CAGR | (6.80%) | +4.23% | +26.96% | +7.48% | +8.22% | +8.10% |
| Dividends CAGR | +9.10% | +8.74% | +46.29% | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
HCA Healthcare, Inc. (HCA)
| Year | Start price | End price | HCA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $466.86 | $426.94 | (8.23%) | +11.72% | (19.95%) |
| 2025 | $300.15 | $466.86 | +56.71% | +17.72% | +38.99% |
| 2024 | $270.68 | $300.15 | +11.75% | +24.89% | (13.14%) |
| 2023 | $239.96 | $270.68 | +13.82% | +26.19% | (12.37%) |
| 2022 | $256.92 | $239.96 | (5.65%) | (18.17%) | +12.52% |
| 2021 | $164.46 | $256.92 | +57.59% | +28.74% | +28.85% |
| 2020 | $147.81 | $164.46 | +11.64% | +18.37% | (6.73%) |
| 2019 | $124.45 | $147.81 | +20.25% | +31.22% | (10.97%) |
| 2018 | $87.84 | $124.45 | +43.38% | (4.56%) | +47.94% |
| 2017 | $74.02 | $87.84 | +18.67% | +21.70% | (3.03%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
